.jpg)
Industry Outlook & Insights
Super Session
Business Strategies
Sheri Dodd
Vice President/ General Manager
Medtronic Care Management Service & Non-Intensive Diabetes Therapies
Michael Minette
VP of Strategy, Orthopedics Group
Zimmer Biomet
Michael Apkon, MD, PhD
President / CEO
Tufts Medical Center
Pedro Arboleda, MBA
Managing Director
Deloitte
Luba Greenwood
Strategic Business Development and Corporate Ventures
Verily, a Google company
Twenty years from now, the health care system we know today will look completely different. There will be a fundamental shift from “health care” to “health.” And while disease will never be completely eliminated, through science, data, and technology, we will be able to identify it earlier, intervene proactively, and better understand its progression. Greater data connectivity and interoperability, open, secure platforms, and increasing consumer engagement will lead to a future focused on wellness and managed by companies that assume new roles to create value. Ten stakeholder archetypes—grouped into three distinct, but interconnected, categories—are likely to emerge and replace and redefine traditional industry roles.
Today, no segment of health care ecosystem is immune to these transformative changes. Industry leaders need to make choices now about which core capabilities they will need to lead on, and which they will need to partner with others on, over the next 5, 10 and 20 years. This session will challenge MedTech executives to think differently about the future – both in the shorter-term and longer-term - and the business model choices they need to make to survive in this type of health ecosystem.
